Concepedia

O-099 XYOTAX™ vs. docetaxel for the second-line treatment of non-small cell lung cancer (NSCLC): The STELLAR 2 phase III study

P. Bonomi, Luis Paz‐Ares, Corey J. Langer, Mary O’Brien, R. Gervais, U. Gatzemeier, Pavel Reiterer, Helen J. Ross, Jean‐Marie Vandenbulcke

Lung Cancer · 2005 · 12 citations · 0 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyOncology PharmacotherapyLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentSecond-line Chemotherapy